Imaging covers the ways of seeing cancer inside the body without cutting, from X-rays to tracers that light up a single protein.
Anatomic imaging (CT, MRI, ultrasound) shows shape and size. Functional and molecular imaging (PET, SPECT) shows biology: glucose uptake, receptor expression, immune cell presence. The frontier is target-specific PET that predicts whether a targeted drug will work, and imaging that reads out treatment response within days rather than months.
Software that reads scans alongside radiologists, catching cancers earlier and predicting who is at risk.
Aidoc CARE is one radiology foundation model, pretrained on CT scans without labels, whose task-specific heads have each been FDA-cleared to flag urgent findings in emergency scans so radiologists read those first. Its oncology relevance is indirect, catching incidental masses; the regulatory evidence covers triage, not diagnostic accuracy for tumours.
A radiotherapy machine with PET detectors built in: the tumour's own radioactive tracer signal tells the beam where to fire, hundreds of times a second, so moving tumours and several metastases can be tracked and treated without external markers.
A girl who had radiotherapy to the chest carries a risk of breast cancer by age 50 of about 30 per cent. It is not only about dose: a low dose to the whole lung gave a higher standardised incidence than a high dose to a smaller field, because volume matters. Surveillance is recommended from early adulthood, decades before ordinary screening starts.
Breast MRI is the most sensitive breast scan, done lying face down with the breasts in a special coil. Abbreviated protocols cut the scan from half an hour to a few minutes, which makes MRI screening of women with dense breasts or high risk affordable.
CAIX PET is a scan using an antibody against a protein almost unique to clear-cell kidney cancer, to tell cancer from benign kidney lumps without a biopsy.
Devices that look beneath the skin surface without cutting: one scans cells with a laser at microscope resolution, another builds a cross-section with infrared light. Both help decide whether a suspicious mole or patch needs a biopsy, and which edge to cut to.
A mammogram taken after an iodine contrast injection, at two X-ray energies, so that a tumour's blood supply shows up as a bright spot. It gives much of what breast MRI gives on a machine most breast units already own.
A CT scan is a fast 3D X-ray that shows the size and shape of tumours and whether they have spread.
The staging CT scan every cancer patient already has can be measured for muscle and fat at the level of the third lumbar vertebra; low muscle predicts chemotherapy toxicity and shorter survival across cancers, and software now does the measuring automatically.
A model pretrained on 148,000 CT scans to segment organs and triage findings.
The scanners that find and stage cancer are built by five companies in a dozen factories. Detectors, superconducting magnets and the helium that cools them are the parts that run short.
Proton-rich isotopes for PET scans and some therapies are made by hitting a target with a beam from a cyclotron. Fluorine-18 is made every morning within driving distance of the scanner; gallium-68 comes from either a generator or a cyclotron; copper-64 and zirconium-89 last long enough to ship across a country.
CT scanned at two X-ray energies at once, so the scanner can tell iodine contrast from calcium and soft tissue, show exactly how much a tumour enhances, and remove the contrast digitally to save a second scan.
Two upgrades to the ordinary ultrasound machine: elastography measures how stiff a lump is (cancers are usually hard), and microbubble contrast shows how blood flows through it in real time, with no radiation and no kidney-toxic dye.
Endoscopes with an ultrasound probe on the tip, passed down the gullet or windpipe, that see through the wall of the gut or airway to stage tumours and guide a needle into lymph nodes and the pancreas without an operation.
FAPI PET is a PET scan that lights up the scaffolding around almost any solid tumour, including cancers the standard sugar scan misses.
FDG PET is the standard PET scan. A radioactive sugar shows which tissues are burning glucose fast, which most cancers do.
A PET scan using a radioactive form of oestrogen that lights up every tumour deposit still carrying the oestrogen receptor, so doctors can see whether metastases across the body will respond to hormone treatment without biopsying each one.
Injecting a dye that makes tumour glow so the surgeon can see exactly where to cut.
Ultrasound probes the size of a phone that plug into a tablet, costing a few thousand pounds rather than tens of thousands, so a clinic nurse or district doctor can check a breast lump, a swollen neck node or a liver without sending the patient to a city hospital.
HER2 PET is a PET scan using radiolabelled trastuzumab or smaller HER2 binders to map HER2 across all metastases at once.
Independent radiologists who re-read every scan in a trial the same way, so response rates mean the same thing across hospitals.
PET scans built from radiolabelled antibodies or their fragments, to see any protein an antibody can reach, including immune cells inside tumours.
The scanners built into or beside the radiotherapy machine that photograph the patient seconds before the beam fires, so the tumour is where the plan expects and, on the newest machines, so the plan can be redrawn to that day's anatomy.
Cameras in the operating theatre that see dyes the surgeon's eye cannot: green dye lighting up lymph nodes and blood supply, pink glow marking a brain tumour, and even the faint light from a PET tracer in a removed specimen. They turn the dyes into a picture the surgeon follows.
Scanners built into or next to the operating theatre, so the surgeon can check during a brain tumour or spine operation how much tumour is left and remove more before closing.
A yearly low-radiation CT scan for current and former heavy smokers that finds lung cancer early enough to cure it.
Low-dose breast X-ray used for screening. Newer 3D versions find more cancers with fewer false alarms.
The particle accelerators and shielded robotic chemistry boxes that make PET tracers in hospital basements and commercial pharmacies.
Adaptations of Meta's Segment Anything model that outline tumours and organs on any scan with a click.
Merlin is a model trained on 15,000 CT scans with their reports that can find and describe hundreds of findings.
A noradrenaline look-alike that neuroblastoma cells swallow: labelled with a small amount of radioactivity it shows the tumour on a scan; with a large amount it treats it.
MRI uses a strong magnet and radio waves, with no ionising radiation, to picture soft tissue in finer contrast than CT, so it is the standard scan for brain tumours, prostate, rectal cancer staging, liver lesions and breast screening in high-risk women. It is slow, expensive and blurred by movement.
MRI scanners are sold by the strength of their magnet. 1.5 tesla is the reliable workhorse, 3 tesla gives more signal for prostate, brain and breast imaging, and 7 tesla is a research-grade brain scanner; stronger is not simply better, because artefacts, heating and implant restrictions grow with the field.
Multiparametric prostate MRI combines three scan sequences, scored 1 to 5 under PI-RADS, and is done before a first biopsy in men with a raised PSA. Needles go to suspicious areas and men with a negative scan can often avoid biopsy altogether, but about one in ten clinically significant cancers is missed.
England's lung screening programme: people aged 55 to 74 who have ever smoked are invited for a risk assessment and, if high risk, a low-dose CT scan, often in a mobile unit in a supermarket car park.
Nuclear medicine hardware means the scanners themselves: PET/CT, SPECT/CT, and new total-body PET that images the whole body at once.
Dyes that glow under special light, so surgeons can see tumour edges and nerves in the operating theatre.
A PET tracer that measures how much of the DNA repair enzyme PARP a tumour has, to predict response to PARP inhibitors.
A scan that shows where a radioactive tracer accumulates, so it images what tumours are doing rather than what they look like.
Making PSMA, FDG, and new tracers under drug-manufacturing rules and delivering them daily.
Scan after two cycles of chemotherapy; if the tumour has gone dark, give less treatment, and if not, give more. Hodgkin lymphoma pioneered this.
PET and CT in one machine, so hot spots on the PET are pinned to exact locations on the CT.
PET combined with MRI instead of CT, giving biology plus the best soft-tissue detail, at lower radiation dose.
A new kind of CT detector that counts every X-ray photon and records its energy, giving sharper pictures at lower dose and colour-like tissue information from every scan.
Whether men should be screened for prostate cancer is still debated; the modern approach uses a PSA blood test followed by an MRI scan, which finds the cancers that matter while leaving harmless ones alone.
A prostate-cancer-specific PET scan that finds spread far earlier than CT or bone scan, and tells you whether a matched radioactive drug will work.
The numbers pulled from scans that decide whether a cancer is shrinking, growing or dead: tumour diameters for RECIST, sugar uptake on PET, water movement on MRI; they run every trial and most clinic decisions, and they are only as good as the way the scan was taken.
Brighter, longer-lasting fluorescent particles and targeted microbubbles that make tumours visible during surgery or on an ultrasound scan.
An open generalist model that answers questions about 2D and 3D scans.
Measuring, from scans taken after each dose, how much radiation a radioligand actually delivers to the tumour and to kidneys and marrow, so treatment can be personalised.
Turning ordinary CT, MRI and PET scans into hundreds of measured features of shape and texture that computers relate to tumour biology and outcome.
The factories and courier routes that make and deliver short-lived radioactive tracers to hospitals within hours.
A PET scan using a radioactive hormone mimic that lights up neuroendocrine tumours and shows whether the matching radioactive treatment will work.
SPECT and the bone scan are an older type of nuclear scan, still used for bone metastases and to check where a radioactive drug went after treatment.
A gamma camera with a CT scanner bolted on, so a hot spot on a bone scan or a sentinel-node scan is pinned to the exact bone or lymph node, and the dose from a radioactive drug can be measured after treatment.
An ordinary heart ultrasound analysed by software that tracks how far each segment of heart muscle shortens with every beat; a fall of more than about fifteen per cent from baseline warns of chemotherapy heart damage months before the usual ejection fraction measurement moves.
Scanners sensitive enough to image the whole body in seconds at a fraction of the radiation dose, which raises the question of whether healthy people should be scanned at all.
An experimental PET scan that shows whether a tumour carries the TROP2 protein, so doctors could pick the right ADC before giving it.
Ultrasound uses sound waves to make live pictures; it is cheap, safe, and used to guide needles into lumps.
Whole-body MRI is an MRI of the entire body without radiation, used to find spread in myeloma and to screen people with high inherited cancer risk.
The plain X-ray is the oldest and cheapest medical image: a single shadow picture of bone and lung. Fluoroscopy is the live-video version, used to steer needles, catheters and stents during cancer procedures.
The limit of what a prostate scan can be asked to do. It is a good triage test for whether to biopsy and a poor map of where every tumour is, which matters for anyone being offered treatment to part of the gland or follow-up by imaging alone.
Confirmation, by a different route from HD18, that the interim scan can safely direct de-escalation in advanced Hodgkin lymphoma, and that most of the toxicity of escalated BEACOPP can be avoided in the 84 per cent of patients who respond early.
Radiotherapy cannot be omitted in early-stage favourable Hodgkin lymphoma on the basis of a negative interim scan without a clinically relevant loss of tumour control. The scan is better at identifying who needs more than at identifying who needs less.
The interim scan should be used to intensify treatment in early Hodgkin lymphoma, not to withhold radiotherapy. The 99.0 per cent five-year progression-free survival in the scan-negative favourable group with combined-modality treatment is the number any radiotherapy-sparing strategy has to match.
The basis for four cycles of escalated BEACOPP as the German standard when the interim scan is negative, and the reason rituximab was abandoned as an addition to that regimen. The authors recommend the scan-guided strategy for all patients with advanced-stage disease.
The evidence that put a scan in front of the biopsy. It reduces the number of men who are biopsied at all, reduces the number of harmless cancers found, and increases the number of dangerous ones, which is the only combination that improves a screening pathway on both sides at once.
Open-source software, hardware and data projects catalogued by a third party, the Open Medical Registry, that bear on this front. Listing is not endorsement; check each project's own licence and validation before clinical use.
Desktop platform for medical image visualisation, segmentation, registration, and image-guided therapy research.
Toolbox for computational magnetic resonance imaging, providing calibration and iterative reconstruction methods.
Collection of DICOM implementations and clinical imaging archive tooling used in production PACS deployments.
Open-source ultrasound processing modules and building blocks, analogue front ends, FPGA acquisition and pulser boards for do-it-yourself echography.
Streaming framework for medical image reconstruction, used widely for MRI reconstruction pipelines.
Embedded server component of the MaRCoS open magnetic resonance control system, running on the scanner hardware.
Open-source MRI console built on low-cost Zynq FPGA hardware, providing spectrometer and acquisition control.
Zero-footprint web-based DICOM viewer for radiology and clinical research workflows.
Build documentation for an open-source ultra-low-field MRI scanner constructed at Utrecht University, following the Open Source Imaging Initiative design.
Open-source low-field MRI scanner using a 50 mT permanent magnet, portable at roughly 150 kg, for head and extremity imaging.
Compact iCE40 FPGA and Raspberry Pi ultrasound board providing pulse-echo acquisition for imaging and non-destructive testing.
This data-centric AI repository implements a robust deep learning method (LFBNet) for fully automated tumor segmentation in whole-body [18]F-FDG PET/CT images.
30 more on the open tools page →
From the Open Medical Registry (openmedical.sh), an MIT-licensed catalogue of open-source medicine. Blurbs are one line from each registry record; every project keeps its own licence.